Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectivity and Toxicity of Methylsulfonic Apatinib for Extensively Pre-treated Advanced Sarcoma: a Multicentric Retrospective Study in China

NCT03491371 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03491371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03491371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectivity and Toxicity of Methylsulfonic Apatinib for Extensively Pre-treated Advanced Sarcoma: a Multicentric Retrospective Study in China
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2015
Completion date
February 1, 2017
Enrollment
56 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy, toxicity